A must-read review in the @NEJM on the most common cause of chronic liver disease: MASLD. All you need to know: trends, pathogenesis, early detection, co-morbidities, lifestyle changes and novel and future drugs….. https://t.co/epAuzLl6E7

Anytime a patient is referred to me with decompensated cirrhosis for transplant evaluation, I ask myself: is it possible to recompensate it by treating the cause so a transplant can be avoided? All you need to know about this: @NatRevGastroHep 👉 https://t.co/LEB1FIGCq9

Collaborative Study @EASLnews 🇦🇹AT🇩🇰DE🇮🇹IT researchers have shown that the prognosis of #Patients wtih #Cirrhosis #Complications depends on the pattern of #acute (AD) or #nonacute (NAD) #Decompensation @AleksanderKrag @MedUni_Wien et al. https://t.co/jgfXxDeloK

To shorten or not to shorten vasoactive agents after endoscopy....That is the question (We try to address in this IPMA!) https://t.co/UMzG3ggBA9 @drshalimar @drvishal82 @Yujun__Wong @Being_Medico @ShubhamMehtaGI @EASLnews @BavenoCoop @AASLDtweets @LiverFellow @JGHofficial

#KLM2024 Kolkata Liver Meeting takes off with Prof Sanyal @ArunJSanyalVCU speaking on Metabolic Health, Prof Wedemeyer @HeinerWedemeyer on Viral hepatitis, Dr Asisha @AsishaJaneela on liver health priorities and Prof Jalan @RajivJalan1 talking on reducing deaths in cirrhosis.

I glance down at the paperwork my patient has filled out before his visit. Occupation: Retired harbour master. Two things: I’ve never met a harbor master before. And “harbour” with a “u.” Interesting. It’s the little everyday mysteries that I love most. That reveal us. 1/

Original Article Predictors of long-term clinical outcomes after TIPS: An ALTA group study Nobel et al. ​​#LiverX https://t.co/Xyea4ifD2f

https://t.co/8jFd5gq0J2 💥 Recompensation in 24.7% 24.7% of 1152 HCV related cirrhosis patients following SVR-12, portal hypertension progressed in 13.7% and 2.9% had a new development of HCC over 48 months follow-up. Data from Punjab, India 🇮🇳 @RadhaKDhiman

Thrilled to share our latest publication - Predictors of outcome in rodenticidal hepatotoxicity patients managed with low volume plasma exchange #plasmaexchanage #acuteliverfailure #rodenticide https://t.co/DLtUSKOGFU @IJG_Journal @drsanthoshe @ajay_duseja @saulkarpen

From The Hindu Dated June 10, 2024. Low cost MRI machine uses 0.05 T magnets and doesn’t need a shielded room or helium coolant to operate. Deep learning algorithms for resolution correction.Can be plugged into standard wall-power outlets. #livertwitter

#livertwitter #gitwitter #plasmaexchangeforLiver @IndianApheresis @ASFA

Dear public , This message is for recent havoc created regarding “Covishield Vaccine” stating that it causes Blood clots (thrombosis) and reduced platelets (thrombocytopenia) Let’s clear some facts : • There is not a single vaccine/drug ever produced which doesnt have any

Many @INCIndia handles are spreading a misleading narrative that COVID-19 vaccination was more harmful than not taking it. Please be aware that many studies have established the net benefits of this vaccine. The AstraZeneca news doing the rounds doesn't change that. #Covishield

Happy to share our narrative review on #AcuteLiverFailure in #pregnancy @IJG_Journal https://t.co/YHXoTw2zWw

Was fortunate to be a part of this wonderful initiative - SHARP 2024. Thank you so much for this opportunity @ArunSanyal58975 @saulkarpen @ajay_duseja @INASL_Liver and Dr. Abhijit. Look forward to working together @DrArunKValsan @doc_arka @drsanthoshe @RohitMehtaniDM

Hyperfine Swoop low-field portable MRI scanner procured recently, making CMC Vellore #first hospital in the country to have this state-of-the-art, AI-powered scanner; magnetic field of only 0.064 T, making it safer & more energy-efficient than traditional MRI scanners. #radiology

'Hub & Spoke' model is a pathway for urgent #plasmaexchange for rodenticide ingestion induced #liverfailure in #TamilNadu #India. This model could be replicable in low-resource settings for saving people with acute liver failure of diverse aetiologies https://t.co/N0qiE4NQ9h

https://t.co/s3KEYrV4Ej

The “#HubandSpoke” model: a pathway for urgent #plasmaexchange to treat patients with #rodenticide ingestion induced #acuteliverfailure in Tamil Nadu, India. Read about this phenomenal initiative under the TAEI-NHM @NHM_TN @OffCMCVellore @LancetRH_SEAsia https://t.co/aoOjLwimYb

OCEAN study: The first randomized controlled study to compare octreotide treatment with standard of care in patients with angiodysplasia-related bleeding @Joostphdrenth @LiaGoltstein @LucasBernts https://t.co/1Os96EgXPV